IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Silo Pharma Inc (SILO)

CUSIP: 82711P300 | NYSE | 10 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIntracoastal Capital LLC176,16510.0%+50,904Sep 30, 2026No 13F filer matched
13GAdvisorShares Trust75,5826.7%New 5%+ stakeJun 30, 2026

Institutional Holders — Q3 2026

AdvisorShares Investments LLC103,472
0.0% of portfolio›$156.2K
Geode Capital Management, LLC11,283
0.0% of portfolio›$17.0K
FNY Investment Advisers, LLC5,000
0.0% of portfolio›$7
UBS Group AG337
0.0% of portfolio›$509
Harbour Investments, Inc.14
0.0% of portfolio›$21
StyleTurnoverLocationFiled
AdvisorShares Investments LLC
103,472$156.2K0.0%Deep ValueVery HighBethesda, MD2026-11-09
Geode Capital Management, LLC
11,283$17.0K0.0%IndexVery LowBoston, MA2026-11-06
FNY Investment Advisers, LLC
5,000$70.0%GrowthVery HighNew York, NY2026-10-16
UBS Group AG
337$5090.0%CoreMediumZurich, Switzerland2026-11-10
Harbour Investments, Inc.
14$210.0%ETFLowMadison, WI2026-11-09
No 13F filer matched
13G/AIntracoastal Capital LLC176,165
10.0% of class · Sep 30, 2026+50,904
No 13F filer matched
13GAdvisorShares Trust75,582
6.7% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched